MAPK9 and stroke disorder: Ginsenoside Rg1 could promote the proliferation, differentiation, and maturity of NSCs through ERK1/2, Hes1 PI3K-AKT pathway, and p38 and JNK2 phosphorylation were under control after the admission of it in stroke models.